COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,588 Articles (22,415 medRxiv, 8,173 bioRxiv)

Most recent first Previous |  Page 1729: Articles 17281-17290  | Next

Severe SARS-CoV-2 infection induces a distinct nasal cytokine profile
Morton, B., Barnes, K., Anscombe, C., Jere, K., Kamng'ona, R., Brown, C., Nyirenda, J., Phiri, T., Banda, N. P., Van der veer, C., Mndolo, K. S., Mponda, K., Rylance, J., Phiri, C., Mallewa, J., Nyirenda, M., Katha, G., Kambiya, P., Jafali, J., Mwandumba, H., Gordon, S., Cornick, J., Jambo, K. C., Blantyre COVID-19 consortium
10.1101/2021.02.15.21251753 — Posted: 2021-02-18
Quantification of the tradeoff between test sensitivity and test frequency in COVID-19 epidemic - a multi-scale modeling approach
Forde, J. E., Ciupe, S. M.
10.1101/2021.02.15.21251791 — Posted: 2021-02-18
Artificial Intelligence Applications for COVID-19 in Intensive Care and Emergency Settings: A Systematic Review
Chee, M. L., Ong, M. E. H., Siddiqui, F. J., Zhang, Z., Lim, S. L., Ho, A. F. W., Liu, N.
10.1101/2021.02.15.21251727 — Posted: 2021-02-18
Circulating SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
Garcia-Beltran, W. F., Lam, E. C., St. Denis, K., Nitido, A. D., Garcia, Z. H., Hauser, B. M., Feldman, J., Pavlovic, M. N., Gregory, D. J., Poznansky, M. C., Sigal, A., Schmidt, A. G., Iafrate, A. J., Naranbhai, V., Balazs, A. B.
10.1101/2021.02.14.21251704 — Posted: 2021-02-18
FDA-authorized COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
Pawlowski, C., Lenehan, P., Puranik, A., Agarwal, V., Venkatakrishnan, A., Niesen, M. J., O Horo, J. C., Badley, A. D., Halamka, J., Soundararajan, V.
10.1101/2021.02.15.21251623 — Posted: 2021-02-18 Discussion: Onsite | Offsite
Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 Disease
Serrano, G. E., Walker, J. E., Arce, R., Glass, M. J., Vargas, D., Sue, L., Intorcia, A. J., Nelson, C. M., Oliver, J., Papa, J., Russell, A., Suszczewicz, K. E., Borja, C., Belden, C., Goldfarb, D., Shprecher, D., Atri, A., Adler, C. H., Shill, H. A., Driver-Dunckley, E., Mehta, S. H., Readhead, B., Huentelman, M. J., Peters, J. L., Bimi, C., Mizgerd, J. P., Reiman, E. M., Montine, T. J., Desforges, M., Zehnder, J. L., Sahoo, M. K., Zhang, H., Solis, D., Pinsky, B. A., Deture, M., Dickson, D. W., Beach, T. G.
10.1101/2021.02.15.21251511 — Posted: 2021-02-18
SARS-CoV-2 Seroprevalence Survey Among District Residents Presenting for Serologic Testing at Three Community Based Test Sites in Washington, DC, July to August, 2020
Sherman, A., Reuben, J., David, N. S., Quasie-Woods, D. P., Gunn, J. K. L., Nielson, C. F., Lloyd, P., Yohannes, A., Puckett, M., Powell, J. A., Leonard, S., Iyengar, P., Johnson-Clarke, F., Tran, A., McCarroll, M., Raj, P., Davies-Cole, J., Smith, J., Ellison, J. A., Nesbitt, L.
10.1101/2021.02.15.21251764 — Posted: 2021-02-18
Development and validation of a dynamic 48-hour in-hospital prognostic risk stratification for COVID-19 in a UK teaching hospital: a retrospective cohort study
Wiegand, M., Cowan, S. L., Waddington, C. S., Halsall, D. J., Keevil, V. L., Tom, B. D. M., Taylor, V., Gkrania-Klotsas, E., Preller, J., Goudie, R. J.
10.1101/2021.02.15.21251150 — Posted: 2021-02-18 Discussion: Onsite
Excess Mortality in Suicide caused by COVID-19 in Japan
Kurita, J., Sugishita, Y., Sugawara, T., Ohkusa, Y.
10.1101/2021.02.13.21251670 — Posted: 2021-02-18
COVID-19 Associated Stroke--A Single Centre Experience
Sundar, U., Karnik, N., Mukhopadhyay, A., Darole, P., Kolte, S., Bansal, A., Gokhale, Y., Asole, D., Joshi, A., Pednekar, S., Chavan, S., Trivedi, T., Padwal, N., Kalekar, L., Londhe, C., Padhiyar, R., Pandey, D., Yadav, D., Honrao, S., Bhavsar, P., Shah, P., Gosavi, S., Wadal, A., Shingare, A., Trivedi, M., Pathak Oak, G.
10.1101/2021.02.15.21249420 — Posted: 2021-02-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).